LA JOLLA, Calif.--(BUSINESS WIRE)--Traversa Therapeutics, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of RNAi Delivery Technologies, today announced the appointment of Barry Toyonaga, Ph.D. to the position of Senior Vice President, Business Development. Dr. Toyonaga will be a member of Traversa’s senior management team and will be responsible for the development and execution of global strategic partnering related to human therapeutics and enablement of high-throughput screening.
